• Mission
  • Overview
  • Primary Target
  • Technology
  • Clinical
  • Market
  • Team
  • For Investors
  • Intellectual Property
  • Publications
  • News
  • Contact



Copyright © 2013-2017
ILiAD Biotechnologies
All rights reserved.


News

Date

Title

February 19, 2016

Phase 1b Clinical Trial of BPZE1 Pertussis Vaccine Completes Enrollment of Randomized Study Groups

 

 

January 8, 2014

ILiAD Biotechnologies, Inserm and Inserm Transfert SA, and Institut Pasteur de Lille Enter Scientific Collaboration and Worldwide License Agreements for Vaccine Technology